Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
for
Extensive-Stage Small Cell Lung Cancer
Location: Seattle WA, Edmonds WA, Bismarck ND, Albuquerque NM,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06646276
Phase 3, Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
for
Systemic Lupus Erythematosus,
Location: Seattle WA, Aurora CO, Scottsdale AZ, Rochester MN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06570798
Phase 2, Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
for
Advanced Melanoma
Location: Seattle WA, Edmonton, Salt Lake City UT, Los Angeles CA,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT06112314
Phase 3, Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Seattle WA, Vancouver WA, Vancouver, Eugene OR, Calgary,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for
Adjustment Disorder
Location: Seattle WA, Santa Rosa CA, Draper UT, Aurora CO,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07002034
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The OBSERVE Protocol
for
Major Depression Disorder
Location: Seattle WA, Bellaire TX, Nashville TN, Atlanta GA,
Sponsor: Yale University
Sex: All
Age: 0+
Code: NCT06725277
Recruiting
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Ductal Adenocarcinoma,
Location: Seattle WA, Newport Beach CA, Dallas TX, Houston TX,
Sponsor: PanTher Therapeutics
Sex: All
Age: 18+
Code: NCT06673017
Phase 1, Recruiting
Pre-operative Education Modalities to Decrease Opioid Use
for
Prostatectomy, Opioid-Related Disorders
Location: Seattle WA
Sponsor: Benaroya Research Institute
Sex: Male
Age: 18+
Code: NCT04933084
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Seattle WA, Spokane WA, Los Angeles CA, Orange CA,
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All
Age: 18+
Code: NCT05440708
Phase 1, Phase 2, Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Seattle WA, Boise ID, Calgary, Los Angeles CA,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer
for
Pancreatic Adenocarcinoma
Location: Seattle WA
Sponsor: Benaroya Research Institute
Sex: All
Age: 18+
Code: NCT03703063
Phase 1, Recruiting
Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology
for
Pancreatic Adenocarcinoma
Location: Seattle WA
Sponsor: Benaroya Research Institute
Sex: All
Age: 18+
Code: NCT03703089
Phase 1, Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Seattle WA, Tacoma WA, Redwood City CA, Lancaster CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase 3, Recruiting
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population